Financial results - NEUROMED S.R.L.

Financial Summary - Neuromed S.r.l.
Unique identification code: 7067245
Registration number: J40/1129/1995
Nace: 8621
Sales - Ron
279.977
Net Profit - Ron
-7.708
Employee
8
The most important financial indicators for the company Neuromed S.r.l. - Unique Identification Number 7067245: sales in 2023 was 279.977 euro, registering a net profit of -7.708 euro and having an average number of 8 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Neuromed S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 136.689 136.268 160.515 174.950 201.516 235.655 201.294 281.229 264.361 279.977
Total Income - EUR 136.689 137.247 160.527 174.950 201.544 238.815 204.529 285.998 264.362 279.977
Total Expenses - EUR 137.150 141.724 162.496 170.485 191.036 233.937 211.237 281.973 254.767 284.884
Gross Profit/Loss - EUR -460 -4.476 -1.970 4.466 10.508 4.878 -6.708 4.025 9.594 -4.908
Net Profit/Loss - EUR -797 -4.476 -2.684 -1.242 8.493 2.490 -8.631 1.165 7.003 -7.708
Employees 9 10 9 8 8 10 8 8 8 8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 6.2%, from 264.361 euro in the year 2022, to 279.977 euro in 2023. The Net Profit decreased by -6.982 euro, from 7.003 euro in 2022, to 0 in the last year.

Check the financial reports for the company - Neuromed S.r.l.

Rating financiar

Financial Rating -
Neuromed S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Neuromed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Neuromed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Neuromed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Neuromed S.r.l. - CUI 7067245

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 29.155 21.380 17.109 12.227 33.377 63.245 52.782 23.043 20.421 24.050
Current Assets -3.163 -6.619 -7.037 2.862 115 -8.257 -5.020 12.989 8.466 14.947
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 506 1.556 1.475 1.658 184 5.238 6.739 7.031 7.218 14.900
Cash -3.669 -8.175 -8.512 1.205 -69 -13.494 -11.759 5.958 1.248 47
Shareholders Funds 5.087 653 -2.038 -3.246 5.307 2.540 -6.139 -4.838 49 -7.659
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 20.904 14.108 12.110 18.336 30.334 52.486 53.902 40.869 28.838 46.656
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 14.947 euro in 2023 which includes Inventories of 0 euro, Receivables of 14.900 euro and cash availability of 47 euro.
The company's Equity was valued at -7.659 euro, while total Liabilities amounted to 46.656 euro. Equity decreased by -7.708 euro, from 49 euro in 2022, to -7.659 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Neuromed S.r.l.

Comments - Neuromed S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.